Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ABBOTT INDIA ASTRAZENECA PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 88.9 48.7 182.7% View Chart
P/BV x 16.1 15.5 104.0% View Chart
Dividend Yield % 0.3 1.4 22.4%  

Financials

 ASTRAZENECA PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
ABBOTT INDIA
Mar-22
ASTRAZENECA PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs4,58023,902 19.2%   
Low Rs2,52914,553 17.4%   
Sales per share (Unadj.) Rs322.22,315.0 13.9%  
Earnings per share (Unadj.) Rs24.6375.9 6.6%  
Cash flow per share (Unadj.) Rs31.4407.0 7.7%  
Dividends per share (Unadj.) Rs10.00275.00 3.6%  
Avg Dividend yield %0.31.4 19.7%  
Book value per share (Unadj.) Rs203.81,306.2 15.6%  
Shares outstanding (eoy) m25.0021.25 117.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.08.3 132.8%   
Avg P/E ratio x144.351.2 282.0%  
P/CF ratio (eoy) x113.147.2 239.5%  
Price / Book Value ratio x17.414.7 118.5%  
Dividend payout %40.673.2 55.5%   
Avg Mkt Cap Rs m88,863408,573 21.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3025,795 39.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,05649,193 16.4%  
Other income Rs m148774 19.1%   
Total revenues Rs m8,20449,967 16.4%   
Gross profit Rs m86210,875 7.9%  
Depreciation Rs m170661 25.6%   
Interest Rs m10191 5.0%   
Profit before tax Rs m83010,797 7.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2142,810 7.6%   
Profit after tax Rs m6167,987 7.7%  
Gross profit margin %10.722.1 48.4%  
Effective tax rate %25.826.0 99.2%   
Net profit margin %7.616.2 47.1%  
BALANCE SHEET DATA
Current assets Rs m7,65338,530 19.9%   
Current liabilities Rs m3,92312,032 32.6%   
Net working cap to sales %46.353.9 86.0%  
Current ratio x2.03.2 60.9%  
Inventory Days Days616 1,002.0%  
Debtors Days Days392 1,820.1%  
Net fixed assets Rs m2,1203,541 59.9%   
Share capital Rs m50213 23.5%   
"Free" reserves Rs m5,04427,544 18.3%   
Net worth Rs m5,09427,756 18.4%   
Long term debt Rs m00-   
Total assets Rs m9,77342,072 23.2%  
Interest coverage x88.457.5 153.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.2 70.5%   
Return on assets %6.419.4 32.9%  
Return on equity %12.128.8 42.0%  
Return on capital %16.539.6 41.6%  
Exports to sales %00.7 0.0%   
Imports to sales %31.710.2 309.6%   
Exports (fob) Rs mNA350 0.0%   
Imports (cif) Rs m2,5525,034 50.7%   
Fx inflow Rs m442415 106.6%   
Fx outflow Rs m2,5525,117 49.9%   
Net fx Rs m-2,110-4,702 44.9%   
CASH FLOW
From Operations Rs m1,0089,477 10.6%  
From Investments Rs m47-3,958 -1.2%  
From Financial Activity Rs m-95-6,374 1.5%  
Net Cashflow Rs m961-856 -112.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 3.8 8.1 47.3%  
FIIs % 2.5 0.2 1,245.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   49,085 83,526 58.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Abbott India Share Price Performance

Period ASTRAZENECA PHARMA Abbott India S&P BSE HEALTHCARE
1-Day -1.56% -1.69% -0.10%
1-Month -3.79% 3.01% -1.99%
1-Year 5.50% 6.11% -5.62%
3-Year CAGR 5.18% 16.96% 20.96%
5-Year CAGR 24.13% 29.54% 11.47%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Abbott India paid Rs 275.0, and its dividend payout ratio stood at 73.2%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.